Crystal structure of SARS-CoV-2 nsp10/nsp16 2'-O-methylase and its implication on antiviral drug design

Signal Transduct Target Ther. 2020 Jul 29;5(1):131. doi: 10.1038/s41392-020-00241-4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / chemistry
  • Betacoronavirus / chemistry
  • Betacoronavirus / drug effects
  • Betacoronavirus / genetics
  • Betacoronavirus / ultrastructure*
  • COVID-19
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / genetics
  • Coronavirus Infections / virology*
  • Crystallography, X-Ray
  • Drug Design
  • Humans
  • Methyltransferases
  • Pandemics
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / genetics
  • Pneumonia, Viral / virology*
  • Protein Conformation / drug effects
  • S-Adenosylmethionine / chemistry
  • SARS-CoV-2
  • Viral Nonstructural Proteins / antagonists & inhibitors
  • Viral Nonstructural Proteins / chemistry*
  • Viral Nonstructural Proteins / ultrastructure
  • Viral Regulatory and Accessory Proteins / antagonists & inhibitors
  • Viral Regulatory and Accessory Proteins / chemistry*
  • Viral Regulatory and Accessory Proteins / ultrastructure
  • tRNA Methyltransferases / antagonists & inhibitors
  • tRNA Methyltransferases / chemistry

Substances

  • Antiviral Agents
  • NSP10 protein, SARS-CoV-2
  • NSP16 protein, SARS-CoV-2
  • Viral Nonstructural Proteins
  • Viral Regulatory and Accessory Proteins
  • S-Adenosylmethionine
  • Methyltransferases
  • tRNA Methyltransferases